Resultados de procura - Massimo Di Maïo

Limitar resultados
  1. 1
    Quality of Life in elderly patients with cancer.

    Quality of Life in elderly patients with cancer. por Massimo Di Maïo, Federica Perrone

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles

    Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles por Antônio Rossi, Massimo Di Maïo

    Publicado 2016
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    A review of guidelines for lung cancer

    A review of guidelines for lung cancer por Paolo Bironzo, Massimo Di Maïo

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review

    Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review por Anna Amela Valsecchi, Massimo Di Maïo

    Publicado 2025
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Real-World Evidence in Oncology: Opportunities and Limitations

    Real-World Evidence in Oncology: Opportunities and Limitations por Massimo Di Maïo, Francesco Perrone, Pierfranco Conté

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

    Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials por Francesco Facchinetti, Massimo Di Maïo, Marcello Tiseo

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomy

    A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomy por Massimo Di Maïo, Federica Perrone, Claude Deschamps, Gaetano Rocco

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice

    COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice por Laura Marandino, Andrea Necchi, Massimo Aglietta, Massimo Di Maïo

    Publicado 2020
    Ligazón do recurso
    Editorial
    Engadir a favoritos
    Gardado en:
  9. 9
    Papillary renal cell carcinoma: A review of the current therapeutic landscape

    Papillary renal cell carcinoma: A review of the current therapeutic landscape por Giulia Courthod, Marcello Tucci, Massimo Di Maïo, Giorgio V. Scagliotti

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis

    Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-... por Alfredo Addeo, Giuseppe Luigi Banna, Giulio Metro, Massimo Di Maïo

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions

    Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions por Alessandro Morabito, Ermelinda De Maio, Massimo Di Maïo, Nicola Normanno, Federica Perrone

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer

    Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer por Consuelo Buttigliero, Marcello Tucci, Francesca Vignani, Giorgio V. Scagliotti, Massimo Di Maïo

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer

    Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer por Francesca Vignani, Valentina Bertaglia, Consuelo Buttigliero, Marcello Tucci, Giorgio V. Scagliotti, Massimo Di Maïo

    Publicado 2016
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions

    Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions por Marcello Tucci, Clizia Zichi, Consuelo Buttigliero, Francesca Vignani, Giorgio V. Scagliotti, Massimo Di Maïo

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  15. 15
    Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

    Tackling ALK in non-small cell lung cancer: the role of novel inhibitors por Francesco Facchinetti, Marcello Tiseo, Massimo Di Maïo, Paolo Graziano, Emilio Bria, Giulio Rossi, Silvia Novello

    Publicado 2016
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer

    Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer por Consuelo Buttigliero, Marcello Tucci, Valentina Bertaglia, Francesca Vignani, Paolo Bironzo, Massimo Di Maïo, Giorgio V. Scagliotti

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  17. 17
    Neuroendocrine breast carcinoma: a rare but challenging entity

    Neuroendocrine breast carcinoma: a rare but challenging entity por Elena Trevisi, Anna La Salvia, Lorenzo Daniele, Maria Pia Brizzi, Gaetano De Rosa, Giorgio V. Scagliotti, Massimo Di Maïo

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  18. 18
    Is flexible bronchoscopy necessary to confirm the position of double-lumen tubes before thoracic surgery?☆

    Is flexible bronchoscopy necessary to confirm the position of double-lumen tubes before thoracic surgery?☆ por Mario De Bellis, Rosanna Accardo, Massimo Di Maïo, Carmine Lamanna, Giovanni Battista Rossi, Maria Caterina Pace, Vincenzo Romano, Gaetano Rocco

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer por Massimo Di Maïo, Francesco Perrone, Paolo Chiodini, Ciro Gallo, Carlos Camps, Wolfgang Schuette, Élisabeth Quoix, Chun-Ming Tsai, Cesare Gridelli

    Publicado 2007
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  20. 20
    Implications of KRAS mutations in acquired resistance to treatment in NSCLC

    Implications of KRAS mutations in acquired resistance to treatment in NSCLC por Marzia Del Re, Eleonora Rofi, Giuliana Restante, Stefania Crucitta, E. Arrigoni, Stefano Fogli, Massimo Di Maïo, Iacopo Petrini, Romano Danesi

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: